Advances in the development of new biomarkers for Alzheimer's disease | Translational Neurodegeneration | Full Text
JCM | Free Full-Text | Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment
Frontiers | Manipulation of the diet–microbiota–brain axis in Alzheimer's disease
Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice - The Journal of Nutrition
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
JPM | Free Full-Text | Biomarkers for Alzheimer's Disease Early Diagnosis
Mechanisms of action of anti-Aβ-antibodies. Anti-Aβ-antibodies can... | Download Scientific Diagram
Decreased salivary lactoferrin levels are specific to Alzheimer's disease - eBioMedicine
Blood‐based biomarkers for Alzheimer's disease | EMBO Molecular Medicine
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
IJMS | Free Full-Text | CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
Biomolecules | Free Full-Text | Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
Amyloid blood biomarker detects Alzheimer's disease | EMBO Molecular Medicine
Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease - ScienceDirect
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline | Alzheimer's Research & Therapy | Full Text
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease | Molecular Psychiatry
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease | Translational Psychiatry
New Alzheimer's Biomarkers may Support Early Diagnosis
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments | Cell Research
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect
Identifying and validating biomarkers for Alzheimer's disease: Trends in Biotechnology
Cells | Free Full-Text | Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD - Tramutola - 2015 -
